The regulation of JAKs in cytokine signaling and its breakdown in disease
Top Cited Papers
Open Access
- 1 June 2019
- journal article
- review article
- Published by Elsevier BV in Cytokine
- Vol. 118, 48-63
- https://doi.org/10.1016/j.cyto.2018.03.041
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council of Academy of Finland
- Sigrid Juselius Foundation
- Jane and Aatos Erkko Foundation
- Finnish cancer foundation
- Competitive Research Funding of Tampere University Hospital
- Tampere Tuberculosis Foundation
This publication has 218 references indexed in Scilit:
- Signaling network of Oncostatin M pathwayJournal of Cell Communication and Signaling, 2012
- A Patient with Tyrosine Kinase 2 Deficiency without Hyper-IgE SyndromeThe Journal of Pediatrics, 2012
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated DiseaseImmunity, 2012
- Suppression of Cytokine Signaling by SOCS3: Characterization of the Mode of Inhibition and the Basis of Its SpecificityImmunity, 2012
- Phosphorylation of Y372 is critical for Jak2 tyrosine kinase activationCellular Signalling, 2011
- IFN-λsCurrent Opinion in Immunology, 2011
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid TumorsCancer Cell, 2009
- Structures and biological functions of IL-31 and IL-31 receptorsCytokine & Growth Factor Reviews, 2008
- Receptor tyrosine kinases: mechanisms of activation and signalingCurrent Opinion in Cell Biology, 2007